Pharma Journalist -

Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, announced a four-year global research collaboration with Vertex Pharmaceuticals Incorporated…
Read More...

Reata Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (“FDA”) has approved SKYCLARYS (omaveloxolone) for the treatment of Friedreich’s ataxia in adults and…
Read More...

Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced a multi-year, strategic collaboration with Pfizer in which the two companies are working…
Read More...

Rhythm Pharmaceuticals, Inc. announced that Rhythm’s Netherlands subsidiary, Rhythm Pharmaceuticals Netherlands B.V. (“Rhythm BV”), acquired Xinvento B.V., a Netherlands-based biotech…
Read More...

Azenta, Inc. announced the launch of the Cryo Store Pico™ ("Pico"), a novel automated cryogenic storage system designed for high-value biological samples used in the many stages of life…
Read More...

AbbVie announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ, 45 mg and 15 mg and 30 mg…
Read More...

Singleron Biotechnologies, a front-runner in single cell multi-omics analysis, and Macrogen Europe, a state-of-the-art sequencing provider of fast and reliable genome analysis services…
Read More...

Ocugen, Inc. announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial of…
Read More...

Lantern Pharma Inc., a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost,…
Read More...

Keymed Biosciences Inc. and Lepu Biopharma Co., Ltd  jointly announce a global exclusive licence agreement with AstraZeneca for CMG901, a potential first-in-class Claudin 18.2 antibody…
Read More...